People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...

The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older.

Add Yahoo as a preferred source to see more of our stories on Google. With cold and flu season comes an increased risk of sinus infections, which can trigger a runny nose, sinus pressure, congestion ...

The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Navya Mysore, a primary care provider in New York and medical director of women’s health at Nurx, told HuffPost that when our ...

LIBERTY-AFRS-AIMS met its primary endpoint with a 50% reduction in CT sinus opacification at week 52 versus 10% with placebo (P<.0001).

Here's what a neti pot is, when to use one and how to do so safely.

Tezepelumab is associated with beneficial changes in nasal polyp gene expression in patients with chronic rhinosinusitis with ...

Acupuncture can be highly effective in cases of nasal congestion so common in allergy presentations. I use a skeleton ...

Sinusitis, often referred to as a sinus infection, is a condition where the sinus cavities inside the face become swollen and inflamed. This leads to symptoms such as a blocked or runny nose, facial ...

Intuitively, these products should work. But they don’t fix any medical problem when measured objectively or compared against placebo.

Neurent Medical has raised 62.5 million euros ($74 million) to commercialize a device that treats a common nasal condition, the company said Wednesday. The Series C financing will equip Neurent to ...